[Alpha-adrenoceptor stimulation mediated positive chronotropic effect in isolated right heart atria of normotensive and SHRsp rats].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 8352017)

Published in Zhongguo Yao Li Xue Bao on March 01, 1993

Authors

J Gong1, X L Wang, Y F Zheng, X F Wang

Author Affiliations

1: Department of Pharmacology, Chinese Academy of Medical Sciences, Beijing.

Articles by these authors

TGF beta signals through a heteromeric protein kinase receptor complex. Cell (1992) 8.12

Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase. Cell (1992) 4.68

Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci U S A (1995) 4.54

Morbidity and mortality in relation to cigarette smoking in Shanghai, China. A prospective male cohort study. JAMA (1996) 3.77

Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein. Proc Natl Acad Sci U S A (1987) 3.72

Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction. Mol Cell Biol (1999) 3.55

Transcriptional enhancer elements in the mouse immunoglobulin heavy chain locus. Science (1983) 2.75

ATR/ATM-mediated phosphorylation of human Rad17 is required for genotoxic stress responses. Nature (2001) 2.50

Functional analysis of the transforming growth factor beta responsive elements in the WAF1/Cip1/p21 promoter. J Biol Chem (1995) 2.35

A transforming growth factor beta type I receptor that signals to activate gene expression. Science (1994) 2.26

Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein. Mol Cell Biol (1997) 2.25

Angiotensin-converting enzyme genotype in children and coronary events in their grandparents. Circulation (1995) 2.17

Nodeless superconducting gap in A(x)Fe2Se2 (A=K,Cs) revealed by angle-resolved photoemission spectroscopy. Nat Mater (2011) 2.16

Smad3-Smad4 and AP-1 complexes synergize in transcriptional activation of the c-Jun promoter by transforming growth factor beta. Mol Cell Biol (1999) 2.08

Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals. Neurology (2002) 2.00

Host-mediated selection of influenza virus receptor variants. Sialic acid-alpha 2,6Gal-specific clones of A/duck/Ukraine/1/63 revert to sialic acid-alpha 2,3Gal-specific wild type in ovo. J Biol Chem (1985) 1.91

Association study of neuregulin 1 gene with schizophrenia. Mol Psychiatry (2003) 1.89

The role of Smad3 in mediating mouse hepatic stellate cell activation. Hepatology (2001) 1.88

Relationship between homocysteine and superoxide dismutase in homocystinuria: possible relevance to cardiovascular risk. Arterioscler Thromb Vasc Biol (2000) 1.86

Expression of the E2F1 transcription factor overcomes type beta transforming growth factor-mediated growth suppression. Proc Natl Acad Sci U S A (1995) 1.81

Smads bind directly to the Jun family of AP-1 transcription factors. Proc Natl Acad Sci U S A (1999) 1.81

Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J Biol Chem (1994) 1.76

Transforming growth factor beta activates the promoter of cyclin-dependent kinase inhibitor p15INK4B through an Sp1 consensus site. J Biol Chem (1995) 1.72

Absence of TGF-beta receptors and growth inhibitory responses in retinoblastoma cells. Science (1988) 1.72

Quantum criticality and nodal superconductivity in the FeAs-based superconductor KFe2As2. Phys Rev Lett (2010) 1.68

TGF-beta-induced phosphorylation of Smad3 regulates its interaction with coactivator p300/CREB-binding protein. Mol Biol Cell (1998) 1.67

Mammalian dwarfins are phosphorylated in response to transforming growth factor beta and are implicated in control of cell growth. Proc Natl Acad Sci U S A (1996) 1.67

A genetically tractable model of human glioma formation. Cancer Res (2001) 1.63

Analysis of simulated and experimental fluorescence recovery after photobleaching. Data for two diffusing components. Biophys J (1995) 1.60

An evaluation of the TruView EVO2 laryngoscope. Anaesthesia (2007) 1.59

Novel LQT-3 mutation affects Na+ channel activity through interactions between alpha- and beta1-subunits. Circ Res (1998) 1.56

Mechanism of enhancement in electromagnetic properties of MgB2 by Nano SiC doping. Phys Rev Lett (2007) 1.49

Smad5 induces ventral fates in Xenopus embryo. Dev Biol (1997) 1.49

Preserved foods in relation to risk of nasopharyngeal carcinoma in Shanghai, China. Int J Cancer (2000) 1.47

Apolipoprotein screening in Australian children: feasibility and the effect of age, sex, and ethnicity. Med J Aust (1998) 1.45

The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis. J Bone Miner Res (2001) 1.44

Characterisation and validation of a novel panel of the six short tandem repeats for genetic counselling in Chinese haemophilia A pedigrees. Haemophilia (2012) 1.42

Elevated levels of lipoprotein(a) in women with preeclampsia. Am J Obstet Gynecol (1998) 1.40

Lipoprotein(a) and apolipoproteins B and A-1 in children and coronary vascular events in their grandparents. J Pediatr (1993) 1.40

In vivo functional analysis of in vitro protein binding sites in the immunoglobulin heavy chain enhancer. Nucleic Acids Res (1988) 1.39

The endogenous immunoglobulin heavy chain enhancer can activate tandem VH promoters separated by a large distance. Cell (1985) 1.39

Observation of an antimatter hypernucleus. Science (2010) 1.38

Growth hormone increases and insulin-like growth factor-I decreases circulating lipoprotein(a) Eur J Endocrinol (1997) 1.38

Homocysteine, renal disease and cardiovascular disease in a remote Australian Aboriginal community. Intern Med J (2005) 1.38

Nomenclature: vertebrate mediators of TGFbeta family signals. Cell (1996) 1.34

Non-dietary risk factors for nasopharyngeal carcinoma in Shanghai, China. Int J Cancer (2000) 1.33

SV40 enhancer-binding factors are required at the establishment but not the maintenance step of enhancer-dependent transcriptional activation. Cell (1986) 1.32

Prognostic value of lymph node metastases and lymph node ratio in esophageal squamous cell carcinoma. Eur J Surg Oncol (2009) 1.32

Common crystalline and magnetic structure of superconducting A2Fe4Se5 (A=K,Rb,Cs,Tl) single crystals measured using neutron diffraction. Phys Rev Lett (2011) 1.32

Risk factors for surgical site infections after breast surgery: a systematic review and meta-analysis. Eur J Surg Oncol (2012) 1.31

The activity of guanine exchange factor NET1 is essential for transforming growth factor-beta-mediated stress fiber formation. J Biol Chem (2001) 1.31

Apoptosis rate can be accelerated or decelerated by overexpression or reduction of the level of elongation factor-1 alpha. Exp Cell Res (1998) 1.30

Scanning tunneling spectroscopy and vortex imaging in the iron pnictide superconductor BaFe1.8Co0.2As2. Phys Rev Lett (2009) 1.29

Mechanical property, biocorrosion and in vitro biocompatibility evaluations of Mg-Li-(Al)-(RE) alloys for future cardiovascular stent application. Acta Biomater (2013) 1.27

Inhibition of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase pathway induces p53-independent transcriptional regulation of p21(WAF1/CIP1) in human prostate carcinoma cells. J Biol Chem (1998) 1.27

Josephson supercurrent through a topological insulator surface state. Nat Mater (2012) 1.26

Cooperation of Sp1 and p300 in the induction of the CDK inhibitor p21WAF1/CIP1 during NGF-mediated neuronal differentiation. Oncogene (1999) 1.26

Clinical and immunohistochemical evidence for an X linked retinitis pigmentosa syndrome with recurrent infections and hearing loss in association with an RPGR mutation. J Med Genet (2003) 1.26

Molecular mechanisms of transforming growth factor-beta signaling. Endocr Rev (1998) 1.26

The MEK pathway is required for stimulation of p21(WAF1/CIP1) by transforming growth factor-beta. J Biol Chem (1999) 1.25

A common polymorphism of the transforming growth factor-beta1 gene and coronary artery disease. Clin Sci (Lond) (1998) 1.23

The cyclosporin A-sensitive nuclear factor of activated T cells (NFAT) proteins are expressed in vascular smooth muscle cells. Differential localization of NFAT isoforms and induction of NFAT-mediated transcription by phospholipase C-coupled cell surface receptors. J Biol Chem (1998) 1.22

In vitro and in vivo studies on a Mg-Sr binary alloy system developed as a new kind of biodegradable metal. Acta Biomater (2012) 1.21

Corrosion fatigue behaviors of two biomedical Mg alloys - AZ91D and WE43 - In simulated body fluid. Acta Biomater (2010) 1.19

Measurement of the differential branching fraction and forward-backward asymmetry for B --> K(*)l+l-. Phys Rev Lett (2009) 1.17

The viral oncoprotein E1A blocks transforming growth factor beta-mediated induction of p21/WAF1/Cip1 and p15/INK4B. Mol Cell Biol (1997) 1.17

TGF-beta increases retinal endothelial cell permeability by increasing MMP-9: possible role of glial cells in endothelial barrier function. Invest Ophthalmol Vis Sci (2001) 1.16

Anomalous transport properties and phase diagram of the FeAs-based SmFeAsO1-xFx superconductors. Phys Rev Lett (2008) 1.14

Effects of hypoxia on glial cell expression of angiogenesis-regulating factors VEGF and TGF-beta. Glia (1998) 1.13

Transforming growth factor-beta-mediated p15(INK4B) induction and growth inhibition in astrocytes is SMAD3-dependent and a pathway prominently altered in human glioma cell lines. J Biol Chem (1999) 1.11

Smart nanofibers from combined living radical polymerization, "click chemistry", and electrospinning. ACS Appl Mater Interfaces (2009) 1.10

Cigarette smoke activates caspase-3 to induce apoptosis of human umbilical venous endothelial cells. Mol Genet Metab (2001) 1.10

Corrosion resistance and surface biocompatibility of a microarc oxidation coating on a Mg-Ca alloy. Acta Biomater (2010) 1.08

Nitric oxide induces and inhibits apoptosis through different pathways. FEBS Lett (1998) 1.08

The Glu-298-->Asp (894G-->T) mutation at exon 7 of the endothelial nitric oxide synthase gene and coronary artery disease. J Mol Med (Berl) (1999) 1.08

A novel angiogenesis inhibitor impairs lovo cell survival via targeting against human VEGFR and its signaling pathway of phosphorylation. Cell Death Dis (2012) 1.07

Expression of the simian virus 40 large tumor antigen (Tag) and formation of Tag-p53 and Tag-pRb complexes in human brain tumors. Cancer (1999) 1.06

Transforming growth factor beta stimulates the human immunodeficiency virus 1 enhancer and requires NF-kappaB activity. Mol Cell Biol (1998) 1.06

E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites. Proc Natl Acad Sci U S A (1997) 1.05

Observation of a charged charmoniumlike structure in e+ e- → π+ π- J/ψ at sqrt[s] = 4.26  GeV. Phys Rev Lett (2013) 1.05

Smoking, oxidative stress and cardiovascular diseases--do anti-oxidative therapies fail? Curr Med Chem (2007) 1.04

Mesenchymal chondrosarcoma of the jaw--report of a case and review of 41 cases in the literature. Head Neck (1993) 1.03

Effects of alloying elements (Mn, Co, Al, W, Sn, B, C and S) on biodegradability and in vitro biocompatibility of pure iron. Acta Biomater (2010) 1.03

Observation of anomalous upsilon(1S)pi+pi(-) and upsilon(2S)pi+pi(-) production near the upsilon(5S) resonance. Phys Rev Lett (2008) 1.02

Human cytomegalovirus causes endothelial injury through the ataxia telangiectasia mutant and p53 DNA damage signaling pathways. Circ Res (2004) 1.02

Tumor necrosis factor receptor 2 gene (TNFRSF1B) in genetic basis of coronary artery disease. J Mol Med (Berl) (2001) 1.02

Hyperbaric oxygen induces endogenous neural stem cells to proliferate and differentiate in hypoxic-ischemic brain damage in neonatal rats. Undersea Hyperb Med (2008) 1.01

Study of e+ e- → π+ π- J/ψ and observation of a charged charmoniumlike state at Belle. Phys Rev Lett (2013) 1.01

Sp1, but not Sp3, functions to mediate promoter activation by TGF-beta through canonical Sp1 binding sites. Nucleic Acids Res (1998) 1.01

Distribution in healthy and coronary populations of the methylenetetrahydrofolate reductase (MTHFR) C677T mutation. Arterioscler Thromb Vasc Biol (1996) 1.00

Electronic-structure-driven magnetic and structure transitions in superconducting NaFeAs single crystals measured by angle-resolved photoemission spectroscopy. Phys Rev Lett (2010) 0.99

Creutzfeldt-Jakob disease in a Chinese patient with a novel seven extra-repeat insertion in PRNP. J Neurol Neurosurg Psychiatry (2007) 0.99

Electronic structure and unusual exchange splitting in the spin-density-wave state of the BaFe2As2 parent compound of iron-based superconductors. Phys Rev Lett (2009) 0.99

A single heteromeric receptor complex is sufficient to mediate biological effects of transforming growth factor-beta ligands. J Biol Chem (1994) 0.98

Influence of artificial biological fluid composition on the biocorrosion of potential orthopedic Mg-Ca, AZ31, AZ91 alloys. Biomed Mater (2009) 0.98

Hospitalisation associated with the 2009 H1N1 pandemic and seasonal influenza in Hong Kong, 2005 to 2010. Euro Surveill (2012) 0.98

Influence of livestock husbandry on schistosomiasis transmission in mountainous regions of Yunnan Province. Southeast Asian J Trop Med Public Health (1997) 0.97

A juvenile ankylosaur from China. Naturwissenschaften (2001) 0.97

Expression of transforming growth factor beta (TGFbeta) type III receptor restores autocrine TGFbeta1 activity in human breast cancer MCF-7 cells. J Biol Chem (1997) 0.97